Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Advanced Fibrolamellar Hepatocellular Carcinoma
NCT01215565Phase 2Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2009
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in fibrolamellar hepatocellular carcinoma (FLHCC), sponsored by Assistance publique - Hôpitaux de Paris. Started Oct 2009; status: terminated.
02
Drugs
sunitinib
03
Conditions
fibrolamellar hepatocellular carcinoma (FLHCC)
Beyond the preview
Go deeper on NCT01215565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01215565.